Teclistamab,Daratumumab,Pomalidomide,Lenalidomide,Bortezomib,Nirogacestat
Genmab,Janssen,springworks therapeutics,Takeda,bms
['mmsm']
 presenting exciting data from the tec-2 study. tec/dara/len combination. impressive &gt;=vgpr rate of 90% #ash22 #mmsm 
Myeloma Clinician Scientist ??????????????????